About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Efficiency Unleashed: Speeding Up Desktop Applications
In today's fast-paced digital landscape, where efficiency and productivity are paramount, desktop application loading speed has become a critical factor that determines user satisfaction, work…
|
Swift Solutions: Enhancing Mobile App Loading Speed
In today's dynamic mobile landscape, app loading speed has become a critical factor that determines user engagement, brand perception, and ultimately, business success. A slow-loading mobile app…
|
Mastering Website Speed: A Comprehensive Guide
In today's fast-paced digital landscape, website loading speed is no longer a mere afterthought; it's a crucial factor that determines user experience, search engine rankings, and…
|
Financial Insights: Lambda Costs and Efficiency Strategies
In the ever-evolving realm of financial institutions, technology plays a pivotal role in ensuring security, compliance, and innovation. Amazon Lambda, a pioneering serverless computing platform, has…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
